Max Health stock falls 3.84 percent in October 8 trading

Max Health (ISIN INE027H01010) was trading at INR 873.10 on the NSE on October 8, 2026, down 3.84 percent from the previous close. The move places the hospital operator 28.5 percent below its 52-week high of INR 1,221.90, making valuation and operating execution the central issues for shareholders.

The stock sits below its yearly high

Max Health's current session range was INR 872 to INR 903.60, with the share price near the session low. Market capitalization stood at INR 849.8 billion on October 8, 2026, while the 52-week range extended from INR 872 to INR 1,221.90.

The stock's position reflects a sharper market reset than the company's latest operating growth. The distance from the yearly high is a concrete measure of how much expansion optimism has already left the price.

Q1 revenue rose 15.2 percent

According to DSIJ in its August 17, 2026 result update, Max Healthcare reported Q1 FY27 consolidated revenue of INR 28.35 billion, converted from INR 28,350 million, up 15.2 percent year over year and 11.6 percent quarter over quarter.

The same update reported adjusted net profit of INR 3.79 billion, up 3.3 percent year over year, and EBITDA of INR 7.05 billion, up 14.8 percent. Oncology remained a pressure point because the discontinuation of selected chemotherapy drugs reduced oncology's inpatient revenue share to 22 percent from 26 percent in Q1 FY26.

Drug pricing adds a regulatory risk

The Edge Malaysia reported on October 8, 2026 that India's Supreme Court scrutiny of steep medicine markups had pressured hospital stocks after proceedings reported on September 30, 2026. The court questioned compulsory purchases through hospital-linked pharmacies and asked about a uniform 16 percent margin on medicines.

That issue matters because pharmacy and ancillary services can carry higher margins than core treatment revenue. Max Healthcare's Q1 growth therefore has to be weighed against the 200-basis-point quarter-over-quarter EBITDA margin decline cited in the Q1 operating update.

Max Health stock remains near INR 873

Max Healthcare operates 21 facilities with more than 6,100 beds, alongside homecare and pathology businesses, according to Max Healthcare. The combination of 15.2 percent revenue growth and regulatory uncertainty leaves capacity expansion and margin recovery as the key variables behind the stock's next valuation move.

At INR 873.10 on the NSE on October 8, 2026, Max Health stock was trading near its 52-week low, while the company's market capitalization was INR 849.8 billion.

More news and analysis on Max Health stock